Capital Markets, December 2025

TT&A is advising JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal Investment Advisors Limited and Nomura Financial Advisory and Securities (India) Private Limited, on the IPO of Symbiotec Pharmalab Limited

TT&A is advising JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal Investment Advisors Limited and Nomura Financial Advisory and Securities (India) Private Limited, who are acting as the book running lead managers on the IPO of Symbiotec Pharmalab Limited (“Company”) for an amount aggregating to ₹ 21,800.00 million comprising a fresh issue of ₹ 1,500.00 million and an offer for sale of ₹ 20,300.00 million by certain existing shareholders of the Company.

TT&A Team: Abhinav Kumar – Partner; Shubham Sancheti – Managing Associate; Abhishek Iyer; Daniyal Khan; Akshita Sharma; Harsh Shekhar and Jahnavi Seethamraju – Associates

 

Abhinav Kumar

Partner, Mumbai

Disclaimer

By browsing this website you agree that you are, of your own accord, seeking further information regarding TT&A. No part of this website should be construed as an advertisement of or solicitation for our professional services. No information provided on this shall be construed as legal advice.